CSKN PHARMA LIMITED

CSKN Pharma Limited is an active private limited company incorporated on 17 January 2020 under the jurisdiction of England and Wales. Its registered office is at Ground Floor, Cooper House, 316 Regents Park Road, London, N3 2JX. The company is currently subject to a proposal to strike off.

It carries on activities classified under SIC codes 86210 (general medical practice activities) and 96090 (other service activities n.e.c.). The most recent accounts, prepared to 31 March 2024 on a total-exemption-full basis, were filed late. The next accounts are due by 31 March 2026.

A confirmation statement was last made up to 16 January 2026 and is not overdue. The sole director is Dr Oluwafemi Oluwakayode Esho, who is British and resides in the United Kingdom. The company is 75–100% owned by CSKN Holdings Limited, which also holds voting rights and the right to appoint and remove directors. Dr Esho retains the right to appoint and remove directors personally.

There are no charges and no history of insolvency. A compulsory strike-off notice was published on 21 July 2026, and a change to a person with significant control was notified on 9 April 2026.